Guidance

JCVI statement on the nasal spray flu vaccine

Using the nasal spray flu vaccine for the UK childhood influenza immunisation programme: advice from JCVI

Documents

Details

The Joint Committee on Vaccination and Immunisation (JCVI) has reviewed updated data from the 2015 to 2016 season in the UK and other countries on the effectiveness of the nasal spray vaccine, in light of emerging evidence of low effectiveness of the nasal spray vaccine reported in the United States (US).

This statement sets out the committee’s advice for continuation of the childhood influenza immunisation programme in using the live attenuated influenza vaccine (LAIV, the nasal spray vaccine).

Published 26 August 2016